Future of drugs-Heart Disease & Stroke_K-134

Drug Name
K-134
Structure
 Figure JPOXMLDOC01-appb-C000001
Drug Code
K-134
Synonym
OPC-33509
1-cyclopropyl-1-(2-hydroxycyclohexyl)-3-[3-[(2-oxo-1H-quinolin-6-yl)oxy]propyl]urea
Molecular Formula
C22H29N3O4
Innovator
D. Western Therapeutics Institute
Kowa Company, Ltd.
Condition
Arteriosclerosis obliterans
Mechanism of Action
Type 3 cyclic nucleotide phosphodiesterase inhibitors (PDE3 inhibitor)
Clinical Phase
IIb in US

Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’

WhatsApp Group for Pharma Literati